TREVISAN, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 9.501
AS - Asia 7.595
EU - Europa 4.970
SA - Sud America 1.288
Continente sconosciuto - Info sul continente non disponibili 694
AF - Africa 184
OC - Oceania 21
Totale 24.253
Nazione #
US - Stati Uniti d'America 8.787
SG - Singapore 2.758
IT - Italia 1.562
HK - Hong Kong 1.335
CN - Cina 1.197
BR - Brasile 956
VN - Vietnam 956
RU - Federazione Russa 921
CA - Canada 588
DE - Germania 513
IE - Irlanda 499
SE - Svezia 396
BD - Bangladesh 256
FR - Francia 247
IN - India 233
FI - Finlandia 178
GB - Regno Unito 178
ID - Indonesia 144
AR - Argentina 129
KR - Corea 97
IQ - Iraq 92
UA - Ucraina 84
NL - Olanda 80
TR - Turchia 78
PK - Pakistan 65
JP - Giappone 60
PH - Filippine 58
ES - Italia 55
SA - Arabia Saudita 53
ZA - Sudafrica 52
MX - Messico 50
AT - Austria 47
EC - Ecuador 45
VE - Venezuela 45
CO - Colombia 34
MA - Marocco 33
DK - Danimarca 32
PL - Polonia 27
MY - Malesia 26
TN - Tunisia 25
BE - Belgio 23
CL - Cile 23
UZ - Uzbekistan 23
CR - Costa Rica 22
CH - Svizzera 20
TH - Thailandia 19
AU - Australia 18
PE - Perù 18
PY - Paraguay 18
CZ - Repubblica Ceca 17
EG - Egitto 17
JM - Giamaica 16
NP - Nepal 16
AE - Emirati Arabi Uniti 15
IL - Israele 12
JO - Giordania 12
UY - Uruguay 12
IR - Iran 11
KE - Kenya 11
DZ - Algeria 10
ET - Etiopia 10
GR - Grecia 10
HN - Honduras 9
LT - Lituania 9
OM - Oman 9
LB - Libano 8
PS - Palestinian Territory 8
TW - Taiwan 8
AZ - Azerbaigian 7
BG - Bulgaria 7
BO - Bolivia 7
EE - Estonia 7
HR - Croazia 7
KG - Kirghizistan 7
RS - Serbia 7
DO - Repubblica Dominicana 6
HU - Ungheria 6
PT - Portogallo 6
GT - Guatemala 5
NG - Nigeria 5
NO - Norvegia 5
PA - Panama 5
QA - Qatar 5
SK - Slovacchia (Repubblica Slovacca) 5
AL - Albania 4
BH - Bahrain 4
KZ - Kazakistan 4
RO - Romania 4
SI - Slovenia 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
BB - Barbados 3
BY - Bielorussia 3
CM - Camerun 3
CY - Cipro 3
EU - Europa 3
KW - Kuwait 3
MN - Mongolia 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
Totale 23.527
Città #
Singapore 1.568
Hong Kong 1.307
Ashburn 897
San Jose 716
Ann Arbor 669
Toronto 507
Dublin 485
Milan 428
Chandler 403
Fairfield 387
New York 331
Ho Chi Minh City 315
Frankfurt am Main 308
Chicago 286
Santa Clara 246
Los Angeles 236
Princeton 228
Beijing 226
Hanoi 223
The Dalles 211
Houston 195
Hefei 181
Rome 180
Wilmington 177
Woodbridge 175
Seattle 165
Lauterbourg 149
Dallas 142
Helsinki 122
Cambridge 119
Lawrence 108
Jakarta 106
Altamura 99
Seoul 81
São Paulo 80
Council Bluffs 78
Moscow 76
Shanghai 67
Buffalo 61
Nuremberg 57
Boardman 51
Munich 47
San Diego 47
Tokyo 46
London 42
Rio de Janeiro 41
Jacksonville 40
Salt Lake City 40
Baghdad 39
Da Nang 36
Tukwila 33
Chennai 32
Haiphong 32
Brooklyn 30
Orem 30
Dhaka 29
Atlanta 28
Guangzhou 27
Lappeenranta 27
Belo Horizonte 26
Figino 25
Andover 24
Columbus 24
Riyadh 24
Stockholm 24
Curitiba 23
Mumbai 23
Turku 23
Brussels 22
Florence 22
Philadelphia 22
Phoenix 22
Tampa 22
Turin 21
Brasília 20
Dearborn 20
Jeddah 20
Lahore 20
Montreal 20
Nanjing 20
Elk Grove Village 19
Palermo 19
Tashkent 19
Boston 18
Istanbul 18
Memphis 18
Naples 18
San Francisco 18
Washington 18
Amsterdam 17
Johannesburg 17
Miami 17
Biên Hòa 16
Caracas 16
Guayaquil 16
Kent 16
Pune 16
Vienna 16
Warsaw 16
Bergamo 15
Totale 13.902
Nome #
Type 2 diabetes mellitus is associated with faster degeneration of bioprosthetic valve: results from a propensity score-matched Italian multicenter study. 411
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: Impact on cardiovascular events: A randomized controlled trial 377
Postprandial hyperglycemia is associated with an increase of blood pressure in type 1 diabetic patients treated with continuous subcutaneous insulin infusion 362
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial 316
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 297
Strategy to identify subjects with diabetes mellitus more suitable for selective echocardiographic screening: The DAVID-Berg study 295
Effects of a low glycemic index high in fiber diet on blood glucose in women with gestational diabetes 294
Subcutaneous insulin infusion (CSII) in italy: The third national survey [La terapia insulinica sottocutanea continua (CSII) in Italia. Terza indagine nazionale] 289
Independent association of estimated pulse-wave velocity with all-cause mortality in individuals with type 2 diabetes 287
Increased prevalence of autoimmune thyroid disease after COVID-19: A single-center, prospective study 273
Effects of Manidipine and Delapril in Hypertensive Patients With Type 2 Diabetes Mellitus: The Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND) Randomized Clinical Trial 272
Kidney function in acromegaly: evidence from a long-term observational study 267
Antecedent use of renin-angiotensin system inhibitors is associated with reduced mortality in elderly hypertensive Covid-19 patients 265
Continuous subcutaneous insulin infusion in Italy: Third national survey 259
Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study 253
Preventing microalbuminuria with benazepril, valsartan, and benazepril-valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) study 237
Association between inhibitors of the renin-angiotensin system and lung function in elderly patients recovered from severe COVID-19 237
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study 225
Switching from Suspend-Before-Low Insulin Pump Technology to a Hybrid Closed-Loop System Improves Glucose Control and Reduces Glucose Variability: A Retrospective Observational Case-Control Study 223
Open questions on basal insulin therapy in T2D: a Delphi consensus 222
Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) after Liver Transplantation: A Narrative Review of an Emerging Issue 221
Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial 219
Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes 210
Comparison of the night-time effectiveness in achieving glycemic targets in adults with type 1 diabetes of three advanced hybryd closed-loop systems 209
Advanced Hybrid Closed-Loop System Achieves and Maintains Recommended Time in Range Levels for Up To 2 Years: Predictors of Best Efficacy 207
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial 200
Development of a new model of insulin sensitivity in patients with type 2 diabetes and association with mortality 197
Telemedicine home-based management in patients with chronic heart failure and diabetes type II: study protocol for a randomized controlled trial 196
Real-World Insulin Treatment in Pregnant Women with Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System 195
Genitourinary infections in diabetic patients in the new era of diabetes therapy with sodium-glucose cotransporter-2 inhibitors 191
Continuous subcutaneous insulin infusion reduces maternal and neonatal risk in pregnant women with type 1 diabetes: An observational cohort study of 122 pregnancies 188
Pre-gestational diabetes during the COVID-19 pandemic in Bergamo, Italy 186
Influence of dietary fat and carbohydrates proportions on plasma lipids, glucose control and low-grade inflammation in patients with type 2 diabetes—The TOSCA.IT Study 184
Independent association of history of diabetic foot with all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study 183
Prognostic impact of switching to the 2021 chronic kidney disease epidemiology collaboration creatinine-based equation in Caucasian patients with type 2 diabetes: the Renal Insufficiency and Cardiovascular events (RIACE) Italian Multicenter Study 179
Dapagliflozin and cardiovascular outcomes in type 2 diabetes 177
Association between On-Treatment Haemoglobin A1c and All-Cause Mortality in Individuals with Type 2 Diabetes: Importance of Personalized Goals and Type of Anti-Hyperglycaemic Treatment 175
Liver fibrosis assessed by transient elastography is independently associated with albuminuria in the general United States population 174
The Hyperfiltering Kidney in Diabetes 173
Role of continuous glucose monitoring in diabetic patients at high cardiovascular risk: an expert-based multidisciplinary Delphi consensus 172
Blood pressure and metabolic effects of acetyl-L-carnitine in type 2 diabetes: DIABASI randomized controlled trial 171
Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial 171
Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial 171
Preventing microalbuminuria in type 2 diabetes 170
Switching to the Minimed™ 780G system achieves clinical targets for CGM in adults with type 1 diabetes regardless of previous insulin strategy and baseline glucose control 169
"Insulin autoimmune syndrome": Two very different cases [“Insulin autoimmune syndrome”: Due casi molto diversi] 166
Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study 166
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus 165
A holistic approach to managing cardio-kidney metabolic syndrome: insights and recommendations from the Italian perspective 164
Different Times for Different Metrics: Predicting 90 Days of Intermittently Scanned Continuous Glucose Monitoring Data in Subjects With Type 1 Diabetes on Multiple Daily Injection Therapy. Findings From a Multicentric Real-World Study 162
Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and covid-19: A multicenter case-control retrospective observational study 162
Haemoglobin A1c variability is a strong, independent predictor of all-cause mortality in patients with type 2 diabetes 161
Impact of substitution among generic drugs on persistence and adherence: A retrospective claims data study from 2 Local Healthcare Units in the Lombardy Region of Italy 161
Renal hyperfiltration is independently associated with increased all-cause mortality in individuals with type 2 diabetes: A prospective cohort study 160
Does denosumab exert a protective effect against COVID-19? Results of a large cohort study 159
La malattia renale e le sue complicanze: percorso per una diagnosi precoce e gestione multidisciplinare 159
Sodium-glucose transporter 2 inhibitors for renal and cardiovascular protection in US adults with type 2 diabetes: impact of the 2020 KDIGO clinical practice guidelines 159
Maternal glycaemic levels are associated with incidence of large for gestational age neonates in type 1 diabetic women in pregnancy 158
Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre study 155
Gestione multidisciplinare del paziente con sindrome coronarica acuta e diabete mellito: Dalla terapia antitrombotica al trattamento dell'iperglicemia 154
Resilience in pregnant women with pre-gestational diabetes during COVID-19 pandemic: the experience of the Papa Giovanni XXIII Hospital in Bergamo, Italy 153
IDegLira for the Real-World Treatment of Type 2 Diabetes in Italy: Protocol and Interim Results from the REX Observational Study 152
Enhanced effects of insulin and angiotensin II on intracellular pH and free cytosolic calcium in fibroblasts from microalbuminuric patients with non-insulin-dependent diabetes mellitus 150
Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: The TOSCA.IT study 147
Lipids and renal disease 146
Efficacy of pasireotide in controlling severe hypercortisolism until cardiac transplantation 146
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial 146
Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial 145
Elevated risk of death and major cardiovascular events in subjects with newly diagnosed diabetes: Findings from an administrative database 145
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus 144
Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin 143
Relationship between degree of risk factor control and all-cause mortality in individuals with type 2 diabetes: A prospective cohort study 142
Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus 142
Effect of Trandolapril on Regression of Retinopathy in Hypertensive Patients with Type 2 Diabetes: A Prespecified Analysis of the Benedict Trial 141
Effect of Denosumab on Glucose Homeostasis in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors: A Pilot Study 141
Defining the contribution of chronic kidney disease to all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study 140
Efficacy of self-monitoring blood glucose as a key component of a chronic care model versus usual care in type 2 diabetes patients treated with oral agents: results of a randomized trial 140
Readily Available Index of Insulin Sensitivity Is Associated with Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis in Patients with Type 2 Diabetes 139
Hypertriglyceridemia Is Independently Associated with Renal, but Not Retinal Complications in Subjects with Type 2 Diabetes: A Cross-Sectional Analysis of the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study 138
Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus 137
Impact of a complement factor H gene variant on renal dysfunction, cardiovascular events and response to ACE inhibitor therapy in type 2 diabetes 137
Metabolic Syndrome, and Not Obesity, Is Associated with Chronic Kidney Disease 136
Independent correlates of urinary albumin excretion within the normoalbuminuric range in patients with type 2 diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study 135
Liver Stiffness, Albuminuria and Chronic Kidney Disease in Patients with NAFLD: A Systematic Review and Meta-Analysis 135
Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with Type 1 diabetes 134
Sex differences in cardiovascular disease and cardiovascular risk estimation in patients with type 1 diabetes 134
Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial 133
Diabetes mellitus in critical jobs [Diabete mellito in attività lavorative critiche] 132
Retinopathy as an independent predictor of all-cause mortality in individuals with type 2 diabetes 131
Association between age at diagnosis and all-cause mortality in type 2 diabetes: the Renal Insufficiency and Cardiovascular Events (RIACE) Italian Multicenter Study 129
Effect of low-dose ramipril on microalbuminuria in normotensive or mild hypertensive non-insulin-dependent diabetic patients. North-East Italy Microalbuminuria Study Group 129
Treatment of diabetes in patients with kidney disease 128
Cardiovascular complications and drug prescriptions in subjects with and without diabetes in a Northern region of Italy, in 2002 and 2012 128
Reply to "Liver fibrosis assessed by transient elastography and albuminuria" 128
Atrial natriuretic factor in hypertensive and normotensive insulin-dependent diabetics 124
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial 123
Glycated haemoglobin does not accurately predict average capillary glucose in non insulin-treated type 2 diabetes: The PRISMA study experience 122
The high hourly overnight variability of insulin requirements as an explanation for the superiority of automated insulin delivery systems 122
Off-Patent Generic Medicines vs. Off-Patent Brand Medicines for Six Reference Drugs: A Retrospective Claims Data Study from Five Local Healthcare Units in the Lombardy Region of Italy 121
Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease: Results from the CREDENCE trial and meta-analysis 119
Totale 18.217
Categoria #
all - tutte 100.569
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.569


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.103 0 85 90 67 23 42 60 58 41 256 73 308
2022/20231.926 217 589 154 104 165 327 5 84 114 45 64 58
2023/20241.789 53 48 63 68 264 416 302 61 252 43 22 197
2024/20254.762 249 483 171 193 449 222 198 136 745 717 462 737
2025/202611.616 1.113 886 623 999 1.110 587 1.777 586 840 828 1.216 1.051
2026/2027857 534 323 0 0 0 0 0 0 0 0 0 0
Totale 24.253